Nature CommunicationsBiochemistryPeer-reviewed journal article
Structural basis of NSD2 degradation via targeted recruitment of SCF-FBXO22
Kevin Robertson, Sascha Josef AmanniD, Tongkun LiuiD, Adam FunkiD, Xianxi WangiD, Irina GrishkovskayaiD, Aamir Mehmood, John R. Tabor, Jacqueline L. Norris-DrouiniD, C.H. ArrowsmithiD, Jon L. CollinsiD, Yinglong MiaoiD, Michael J. EmanueleiD, David HaselbachiD, Lindsey Ingerman JamesiD, Nicholas Gene BrowniD
Abstract
Targeted protein degradation (TPD) through the ubiquitin-proteasome system is driven by compound-mediated polyubiquitination of a protein-of-interest by an E3 ubiquitin (Ub) ligase. To date, relatively few E3s have been successfully utilized for TPD and the governing principles of functional ternary complex formation between the E3, degrader, and protein target remain elusive. FBXO22 has recently been harnessed by several groups to target different proteins for degradation. FBXO22 recruitment has been enabled through degraders that covalently modify its cysteine residues. Here, we reveal that the aldehyde derivative of UNC10088 promotes cooperative binding of FBXO22 to NSD2, a histone methyltransferase and oncogenic protein, leading to a cryo-EM structure of the full SKP1-CUL1-F-box (SCF)-FBXO22 complex with NSD2. This structure revealed a conformational change in the FBXO22 loop surrounding C326, further exposing the cysteine for covalent recruitment. Additional medicinal chemistry efforts led to the discovery of benzaldehyde-based non-prodrug degraders that similarly engage C326 of FBXO22 and potently degrade NSD2. Furthermore, unlike many degraders, our molecules recruit NSD2 to a different surface of FBXO22 than the known FBXO22 substrate BACH1, allowing for concurrent complex formation and degradation of both the neosubstrate and endogenous substrates. Overall, we demonstrate the biochemical and structural basis for NSD2 degradation, revealing key principles for efficient and selective TPD by SCFFBXO22.
- research focus: protein folding & dynamics
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 2
- FWCI
- 4.13
- Field percentile
- top 9%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Recruitment of FBXO22 for Targeted Degradation of NSD2
D. Y. Nie, J. R. Tabor, … C. Arrowsmith·bioRxiv·Nov 1, 2023
- Development of Degraders and 2-pyridinecarboxyaldehyde (2-PCA) as a recruitment Ligand for FBXO22
Tian Qiu, Zhe Zhuang, … Nathanael S. Gray·bioRxiv·Aug 19, 2025
- Targeted Protein Degradation through E2 Recruitment
N. Forte, D. Dovala, … D. K. Nomura·bioRxiv·Dec 19, 2022
- A CK2-FBXW11 kinase-E3 ubiquitin ligase cascade is a metabolic sensor regulating Tryptophan 2,3-dioxygenase stability
Alina S. Thielen, Bastian Bräuning, … Brenda Arlene Schulman·bioRxiv·Jan 12, 2026
- Harnessing FBXO31 with terminal amide-functionalized molecules for targeted protein degradation
Chenlu Zhang, Xiaokang Jin, … Xiaoyu Zhang·Journal of the American Chemical SocietyPeer-reviewed·Apr 10, 2026
- A CRISPR activation screen identifies FBXO22 as an E3 ligase supporting targeted protein degradation
A. A. Basu, C. Zhang, … X. Zhang·bioRxiv·Sep 15, 2023